Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
2.600
-0.020 (-0.76%)
At close: Jun 29, 2026, 4:00 PM EDT
2.600
0.00 (0.00%)
Pre-market: Jun 30, 2026, 4:04 AM EDT
Anavex Life Sciences Market Cap
Anavex Life Sciences has a market cap or net worth of $240.95 million as of June 29, 2026. Its market cap has decreased by -65.67% in one year.
Market Cap
240.95M
Enterprise Value
109.20M
1-Year Change
-65.67%
Ranking
Category
Stock Price
$2.60
Market Cap Chart
Since October 28, 2015, Anavex Life Sciences's market cap has decreased from $284.60M to $240.95M, a decrease of -15.34%. That is a compound annual growth rate of -1.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 240.90M | -24.27% |
| Dec 31, 2025 | 318.10M | -65.08% |
| Dec 31, 2024 | 910.90M | 19.20% |
| Dec 29, 2023 | 764.20M | 5.86% |
| Dec 30, 2022 | 721.90M | -45.24% |
| Dec 31, 2021 | 1.32B | 264.55% |
| Dec 31, 2020 | 361.60M | 148.69% |
| Dec 31, 2019 | 145.40M | 100.00% |
| Dec 31, 2018 | 72.70M | -48.95% |
| Dec 29, 2017 | 142.40M | -9.24% |
| Dec 30, 2016 | 156.90M | -18.58% |
| Dec 31, 2015 | 192.70M | -32.29% |
| Oct 28, 2015 | 284.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nautilus Biotechnology | 254.16M |
| AC Immune | 253.95M |
| Orchestra BioMed Holdings | 253.89M |
| Fulcrum Therapeutics | 253.21M |
| Foghorn Therapeutics | 247.77M |
| Fate Therapeutics | 244.77M |
| Sol-Gel Technologies | 240.27M |
| Protara Therapeutics | 231.56M |